FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

407100002: Gefitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2004. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2150930012 Gefitinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2158721012 Gefitinib en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gefitinib Is a Antineoplastic agent false Inferred relationship Existential restriction modifier
Gefitinib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Gefitinib Is a Quinazoline true Inferred relationship Existential restriction modifier
Gefitinib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Gefitinib Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Gefitinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Gefitinib Is a Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Gefitinib Has disposition Epidermal growth factor receptor inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient False Gefitinib Inferred relationship Existential restriction modifier
Iressa 250mg tablet Has active ingredient False Gefitinib Inferred relationship Existential restriction modifier
Product containing gefitinib Has active ingredient True Gefitinib Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient False Gefitinib Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has basis of strength substance True Gefitinib Inferred relationship Existential restriction modifier 1
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has precise active ingredient True Gefitinib Inferred relationship Existential restriction modifier 1
Product containing gefitinib in oral dose form (medicinal product form) Has active ingredient True Gefitinib Inferred relationship Existential restriction modifier 1
Gefitinib Has active ingredient True Gefitinib Inferred relationship Existential restriction modifier 1
Product containing only gefitinib in oral dose form (medicinal product form) Has active ingredient True Gefitinib Inferred relationship Existential restriction modifier 1
Gefitinib 250mg tablets (Zentiva Pharma UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Zentiva Pharma UK Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Wockhardt UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Wockhardt UK Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has active ingredient False Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Viatris UK Healthcare Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Genus Pharmaceuticals Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Viatris UK Healthcare Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Genus Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Sandoz Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Sandoz Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Accord Healthcare Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Accord Healthcare Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (Glenmark Pharmaceuticals Europe Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets (A A H Pharmaceuticals Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Iressa 250mg tablets (Originalis B.V.) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Iressa 250mg tablets (Originalis B.V.) 30 tablet Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Iressa 250mg tablets (AstraZeneca UK Ltd) Has active ingredient False Gefitinib Inferred relationship Existential restriction modifier
Product containing precisely gefitinib 250 milligram/1 each conventional release oral tablet Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Gefitinib 250mg tablets 30 tablet Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Iressa 250mg tablets (AstraZeneca UK Ltd) Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier
Iressa 250mg tablets (AstraZeneca UK Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Gefitinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start